Cited 0 times in
P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.